BioSpace News Archive

First Results from Axial’s ASD Program Presented at the International Society for Autism Research (INSAR) Conference

Data readouts in three programs expected in the second calendar quarter of 2018

Initiative expected to save 70,000 business user hours annually, while reducing number of form templates by 28%

FORMA expands translational footprint in Neurodegeneration with ARUK Oxford Drug Discovery Institute

Catalyst Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2018 and provided a corporate update.

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has successfully completed the “pore size studies” on its Cell-in-a Box® capsules that are required by the U.S. Food and Drug Administration (FDA).